| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,675,678 | 1,564,999 | 1,493,263 | 1,664,500 | | Cost of Revenue | 1,383,046 | 1,275,058 | 1,228,622 | 1,452,646 | | | Gross Profit | 292,632 | 289,941 | 264,641 | 211,854 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 160,565 | 153,195 | 141,394 | 138,749 | | Non Recurring | 656 | 7,303 | (7,959) | (880) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 163,091 | 129,443 | 131,206 | 73,985 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (615) | (5,447) | (8,680) | (5,481) | | Earnings Before Interest And Taxes | 143,846 | 142,293 | 122,526 | 84,192 | | Interest Expense |
-
| (956) | 956 | 1,631 | | Income Before Tax | 143,846 | 143,249 | 121,570 | 82,561 | | Income Tax Expense | 23,793 | 44,645 | 43,878 | 39,559 | | Minority Interest | (7,995) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 143,405 | 98,604 | 77,692 | 43,002 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 112,058 | 98,604 | 77,692 | 43,002 | | Preferred Stock And Other Adjustments | 6,049 | (6,049) |
-
|
-
| | | Net Income Applicable To Common Shares | $118,107 | $92,555 | $77,692 | $43,002 |
|
0.11% Nasdaq 
0.01%
Income Statement
